LSL Pharma Group Inc. (TSXV:LSL)
Canada · Delayed Price · Currency is CAD 0.3200
-0.0100 (-3.03%)
At close: Aug 28, 2026
LSL Pharma Group Market Cap
LSL Pharma Group has a market cap or net worth of CAD 40.55 million as of August 28, 2026. Its market cap has decreased by -12.25% in one year.
Market Cap
40.55M
Enterprise Value
90.18M
Revenue
41.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.32
ChartMarket Cap Chart
Since March 2, 2023, LSL Pharma Group's market cap has decreased from 61.67M to 40.55M, a decrease of -34.24%. That is a compound annual growth rate of -11.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 40.55M | -4.42% |
| Dec 31, 2025 | 42.43M | -10.43% |
| Dec 31, 2024 | 47.37M | 18.48% |
| Dec 29, 2023 | 39.98M | -35.17% |
| Mar 2, 2023 | 61.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vext Science | 66.88M |
| Planet 13 Holdings | 63.71M |
| BioNxt Solutions | 44.90M |
| Rubicon Organics | 39.87M |
| ZYUS Life Sciences | 39.86M |
| Optimi Health | 39.22M |
| Voyageur Pharmaceuticals | 38.48M |
| 1CM Inc. | 36.50M |